Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Klea HoldingVMDGF 37 Receivables Turnover is 7.51 as of Dec. 2025. GuruFocus rates VMDGF with a GF Score™ of 37/100 and a GF Value™ of $0.39. The stock has 2 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, Klea Holding ranks better than 92.08% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Klea Holding's Revenue for the
six
months ended in Dec. 2025 was $12.54 Mil. Klea Holding's average Accounts Receivable for the
six
months ended in Dec. 2025 was $1.67 Mil.
Hence, Klea Holding's Receivables Turnover for the
six
months ended in Dec. 2025 was 7.51.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Klea Holding Receivables Turnover Related Terms
Klea Holding Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Klea Holding's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VMDGF vs TMO, DHR, IDXX: Receivables Turnover Comparison
For the Diagnostics & Research subindustry, Klea Holding's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Klea Holding Receivables Turnover vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Klea Holding's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Klea Holding's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Klea Holding (VMDGF) has a Receivables Turnover of 7.51 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Klea Holding and its competitors. According to the industry distribution chart, Klea Holding ranks #16 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 7.9%.
Is Klea Holding's Receivables Turnover too high?
Klea Holding's current Receivables Turnover is 7.51. The Medical Diagnostics & Research industry median Receivables Turnover is 5.38. Klea Holding's value of 7.51 is 39.6% above this industry median. Based on the distribution chart, Klea Holding ranks #16 out of 202 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Klea Holding has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Klea Holding's Receivables Turnover compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Klea Holding ranks #16 out of 202 companies for Receivables Turnover. This places Klea Holding in the top 8% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.38. Klea Holding's value of 7.51 is 39.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Diagnostics & Research company?
The median Receivables Turnover among Medical Diagnostics & Research companies is 5.38, based on 202 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Klea Holding's current Receivables Turnover of 7.51 is 39.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Klea Holding and its competitors. For the Medical Diagnostics & Research industry, the median Receivables Turnover is 5.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Klea Holding's current Receivables Turnover is 7.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Klea Holding stock overvalued right now?
Klea Holding (VMDGF) has a current Receivables Turnover of 7.51. The stock's GF Value™ is $0.39, compared to a current price of $0.20 — trading 48.7% below its estimated fair value. The current Receivables Turnover is 7.51 and 39.6% above the Medical Diagnostics & Research industry median of 5.38. Klea Holding's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Klea Holding (VMDGF), the current Receivables Turnover is 7.51 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Klea Holding (VMDGF) Overvalued in 2026?
Based on GuruFocus' analysis, Klea Holding stock appears to be undervalued.
The current stock price of $0.20 is trading 48.7% below its estimated GF Value™ of $0.39.
Key valuation signals for VMDGF:
Receivables Turnover: 7.51
GF Value™: $0.39 vs. price of $0.20 (48.7% below fair value)
Industry Position: 39.6% above the Medical Diagnostics & Research median (#16 of 202)
No single metric tells the full story. See the VMDGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Klea Holding focused on the acquisition, development and digitalization of companies in multiple sectors. Its development of Smart Salem, the first network of digital medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the Emirates United Arabs, or its Smart Health joint venture developed in Saudi Arabia.
37GF Score
Get the complete analysis for VMDGF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VMDGF has been successfully added to your 
